Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
PUT
Canadian Pacific Kansas City
CP
$82.2B
| $5.69M | ﹤0.01% |
111,500
-8,500
| -7% | -$403K |
|
2752
BOK Financial
BOKF
$8.88B
| $5.69M | ﹤0.01% |
100,857
+5,044
| +5% | +$258K |
|
2753
Patrick Industries
PATK
$2.76B
| $5.69M | ﹤0.01% |
139,293
-37,121
| -21% | -$1.12M |
|
2754
Franco-Nevada
FNV
$45.2B
| $5.68M | ﹤0.01% |
40,716
-342,326
| -89% | -$45.5M |
|
2755
PUT
Jazz Pharmaceuticals
JAZZ
$15.9B
| $5.68M | ﹤0.01% |
51,500
+27,500
| +115% | +$3.04M |
|
|
FUSN
2756
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $5.68M | ﹤0.01% |
+325,001
| New | +$5.66M |
|
2757
iShares US Aerospace & Defense ETF
ITA
$15.1B
| $5.67M | ﹤0.01% |
68,874
+30,094
| +78% | +$2.37M |
|
|
TMHC
2758
DELISTED
Taylor Morrison
TMHC
| $5.67M | ﹤0.01% |
294,048
+281,441
| +2,232% | +$4.43M |
|
2759
CALL
Nasdaq
NDAQ
$54.2B
| $5.66M | ﹤0.01% |
142,200
| – | – |
|
2760
CALL
CF Industries
CF
$17.9B
| $5.66M | ﹤0.01% |
201,100
-39,700
| -16% | -$1.13M |
|
|
PPL
2761
PUT
PPL Corp
PPL
$27.1B
| $5.66M | ﹤0.01% |
218,900
+66,100
| +43% | +$1.72M |
|
2762
PUT
New York Times
NYT
$10.4B
| $5.65M | ﹤0.01% |
134,500
+7,200
| +6% | +$262K |
|
2763
iShares Agency Bond ETF
AGZ
$565M
| $5.65M | ﹤0.01% |
46,658
+37,237
| +395% | +$4.49M |
|
|
LKFT
2764
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.8B
| $5.65M | ﹤0.01% |
28,636
+2,725
| +11% | +$564K |
|
2765
CALL
Fiverr
FVRR
$324M
| $5.64M | ﹤0.01% |
76,400
+38,900
| +104% | +$2M |
|
|
MRTX
2766
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.64M | ﹤0.01% |
49,400
-79,300
| -62% | -$7.69M |
|
2767
PUT
Corteva
CTVA
$51.2B
| $5.63M | ﹤0.01% |
210,300
+135,500
| +181% | +$3.53M |
|
2768
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $5.63M | ﹤0.01% |
+111,609
| New | +$5.59M |
|
2769
PUT
Perrigo
PRGO
$1.81B
| $5.63M | ﹤0.01% |
101,800
-3,500
| -3% | -$184K |
|
2770
Floor & Decor
FND
$6.24B
| $5.62M | ﹤0.01% |
+97,540
| New | +$4.45M |
|
2771
CALL
Molina Healthcare
MOH
$11.1B
| $5.62M | ﹤0.01% |
31,600
-4,200
| -12% | -$715K |
|
2772
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$430M
| $5.62M | ﹤0.01% |
783,600
+708,064
| +937% | +$4.96M |
|
2773
CALL
US Global Jets ETF
JETS
$824M
| $5.62M | ﹤0.01% |
+337,300
| New | +$5.12M |
|
|
WRK
2774
CALL
DELISTED
WestRock Company
WRK
| $5.6M | ﹤0.01% |
198,300
+101,600
| +105% | +$2.89M |
|
2775
CALL
Jack in the Box
JACK
$327M
| $5.6M | ﹤0.01% |
75,600
+19,300
| +34% | +$1.19M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.